Ahead of the start of the Russian law on biomedical cell products as conflict factor medical law
The article is devoted to the description of revealed contradictions of advanced legal regulation of relations arising in connection with the use of biomedical cell products associated with the coming into force of the new Federal law of June 23, 2016 № 180-FZ «On biomedical cell products». Evaluated conceptual apparatus, scope and certain provisions of the statute in relation to the already existing legal norms of the Russian legislation.